美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

賽生藥業

11.15

0.0000

成交量：- -

成交額：- -

市值：5.82億

市盈率：13.60

高：11.15

開：11.15

低：11.15

收：11.15

52周最高：11.43

52周最低：8.55

股本：5,219.20萬

流通股本：4,527.09萬

量比：- -

換手率：- -

股息：- -

股息率：- -

每股收益(TTM):0.8200

淨資產收益率：--

總資產收益率：--

市淨率：2.33

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

公司資料

公司名字：

賽生藥業

交易所：

NASDAQ

成立時間：

- -

員工人數：

- -

公司地址：

- -

官網：

http://www.sciclone.com

郵編：

- -

電話：

- -

傳真：

- -

簡介：

賽生藥業公司組建於1990年，是一家加州公司，並於2003年在特拉華州重新合併。賽生製藥是一家創收，盈利，面向中國的美國專業製藥公司，擁有大量的商業業務和為腫瘤，傳染病，心血管，泌尿系統，呼吸系統和中樞神經系統紊亂的療法產品。該公司致力於通過其強大的銷售和營銷工作和發展盈利能力來加快國際銷售增長。該公司的業務及企業策略主要集中在中國，並通過其多年的營銷經驗，在那裡已經建立了良好的聲譽和強大的品牌，其主導產品是ZADAXIN（日達仙）。該公司認為其優勢地位可以使之從中國的醫藥市場擴張中受益。

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎國際,美股交易,港股交易,交易美股,股票信息,股價,美股行情,美股打新,港股打新,IPO打新,購買美股,全球投資","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/SCLN/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"SCLN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SCLN\",,,,,undefined,":{"symbol":"SCLN","market":"US","secType":"STK","nameCN":"賽生藥業","latestPrice":11.15,"timestamp":1515186000000,"preClose":11.15,"halted":0,"volume":0,"delay":0,"changeRate":0,"floatShares":45270936,"shares":52192000,"eps":0.82,"marketStatus":"未開盤","change":0,"latestTime":"01-05 16:00:00 EST","open":11.15,"high":11.15,"low":11.15,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.82,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1773648000000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":700808400000,"exchange":"NASDAQ","adjPreClose":11.15,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SCLN\",,,,,undefined,":{"symbol":"SCLN","floatShares":45270936,"roa":"--","roe":"--","lyrEps":0,"shares":52192000,"dividePrice":0,"high":11.15,"amplitude":0,"preClose":11.15,"low":11.15,"week52Low":8.55,"pbRate":"2.33","week52High":11.425,"institutionHeld":0.4567,"latestPrice":11.15,"eps":0.82,"divideRate":0,"volume":0,"delay":0,"ttmEps":0.82,"open":11.15,"prevYearClose":11.15},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SCLN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2017-08-09","symbol":"SCLN","fiscalQuarterEnding":"2017/06","expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1502251200000,"reportTimeType":"post","actualEps":0.26},{"market":"US","date":"2017-05-10","symbol":"SCLN","fiscalQuarterEnding":"2017/03","expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1494388800000,"reportTimeType":"post","actualEps":0.29},{"market":"US","date":"2017-03-06","symbol":"SCLN","fiscalQuarterEnding":"2016/12","expectedEps":null,"name":null,"time":"盤前","type":"earning","dateTimestamp":1488776400000,"reportTimeType":"pre","actualEps":0.17},{"market":"US","date":"2016-11-09","symbol":"SCLN","fiscalQuarterEnding":"2016/09","expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1478667600000,"reportTimeType":"post","actualEps":0.19},{"market":"US","date":"2016-08-09","symbol":"SCLN","fiscalQuarterEnding":"2016/06","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1470715200000,"reportTimeType":"","actualEps":0.18}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SCLN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SCLN\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.sciclone.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.015},{"period":"1month","weight":-0.0429},{"period":"3month","weight":-0.0286},{"period":"6month","weight":0.0074},{"period":"1year","weight":0.2011},{"period":"ytd","weight":-0.0288}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"賽生藥業公司組建於1990年，是一家加州公司，並於2003年在特拉華州重新合併。賽生製藥是一家創收，盈利，面向中國的美國專業製藥公司，擁有大量的商業業務和為腫瘤，傳染病，心血管，泌尿系統，呼吸系統和中樞神經系統紊亂的療法產品。該公司致力於通過其強大的銷售和營銷工作和發展盈利能力來加快國際銷售增長。該公司的業務及企業策略主要集中在中國，並通過其多年的營銷經驗，在那裡已經建立了良好的聲譽和強大的品牌，其主導產品是ZADAXIN（日達仙）。該公司認為其優勢地位可以使之從中國的醫藥市場擴張中受益。","exchange":"NASDAQ","name":"賽生藥業","nameEN":"SciClone Pharmaceuticals"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"SCLN\",market:\"US\",,,undefined,":null}}